Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BALANCE-I: Upadacitinib in RA with anti-TNF failure
NCT01960855Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of upadacitinib in rheumatoid arthritis (RA), sponsored by AbbVie Inc.. Started Oct 2013; status: completed.
02
Drugs
upadacitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01960855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01960855.